NQO1*2, the C609T substituted polymorphic form of NQO1, has low NQO1 enzymatic activity compared with wild-type [31] and has been associated with greater risk of cancer incidence including pediatric leukemia [32], colorectal cancer [33], and gastric cardiac carcinoma [34]. Here, NQO1 is linked to cancer.